Treasury yield is hovering just above a six-week low around 4.50% as investors continue to digest Wednesday’s monetary policy update from the Federal Reserve. The U.S. central bank left interest rates ...
The report comes as tech stocks, led by the Magnificent Seven—think Apple, Microsoft, Google, and their mega-cap friends—take ...
Deep-pocketed investors have adopted a bearish approach towards Goldman Sachs Gr (NYSE:GS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
Microsoft (NASDAQ:MSFT) has lagged behind the NASDAQ over the past year but is off to a strong start in 2025, outperforming ...
This particularly applies to tech giants and popular consumer-facing stocks. What if you'd invested in Goldman Sachs (GS) ten years ago? It may not have been easy to hold on to GS for all that ...
Goldman Sachs has initiated coverage of Vera Therapeutics (NASDAQ:VERA) with a buy rating, citing the potential of its drug candidate atacicept and a recent pullback in the stock. The investment bank ...
Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue as China's ...
Fintel reports that on January 27, 2025, Goldman Sachs upgraded their outlook for Twilio (WBAG:TWLO) from Neutral to Buy. There are 1,067 funds or institutions reporting positions in Twilio.
A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...